Allspring Reports A 4.7% Innospec Stake, Held For Clients, Not For Control
A Schedule 13G puts 1,161,421 Innospec shares under Allspring's investment advisers, with a certification of no intent to influence control.
Allspring Global Investments Holdings holds 1,161,421 Innospec shares, or 4.7% of the common stock, according to a Schedule 13G filed Wednesday. The filing is a passive ownership disclosure, and Allspring certifies the shares are not held to influence control of the company.
What the filing says
The Schedule 13G lists a date of event of September 30, 2026. Allspring reports sole voting power over 1,160,597 shares and shared voting power over none.
Allspring filed as a parent holding company. The filing says the shares are owned of record by clients of one or more of its investment advisers, which are identified in an exhibit.
Those clients have the right to receive dividends or sale proceeds from the shares. The filing says no single client is known to have that right over more than 5% of the class, and it lists no exceptions.
What it changes
The filing sets out a passive position, not an activist one. In the signed certification, Allspring says the securities were acquired and are held in the ordinary course of business, and not to change or influence control of Innospec.
The stake sits just under 5% held by clients, so the 4.7% figure belongs to Allspring's advisers as a group, not to any one client account.
In Wednesday trading, as of 1:36 p.m. ET, Innospec shares were at $97.39, down 1.18% from the prior close of $98.55, according to market data. The company's market cap was $2.4 billion at that point.
The filing names no further dates; its own date of event, September 30, 2026, is the reference point for the 4.7% figure.
